SCHEMBL5453395

SCHEMBL5453395

Cc1cnc(C(C)NC(=O)CN2CCc3ccccc3C2)s1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
MAPT P10636 5/20 0.54
L3MBTL1 Q9Y468 3/20 0.54
POLB P06746 2/20 0.52
RAB9A P51151 1/20 0.48
GFER P55789 1/20 0.48
KDM4E B2RXH2 2/20 0.46
PRMT5 O14744 3/20 0.45
WDR77 Q9BQA1 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TSHR P16473 2/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
GAA P10253 1/20 0.45
HTT P42858 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5456248 0.88 MEN1 (0.42) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL5456538 0.79 NPC1 (0.67) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL5451682 0.71 ALDH1A1 (0.64) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL5458578 0.69 POLB (0.74) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL6901966 0.69 ALDH1A1 (0.61) MEN1KMT2AMAPTRAB9AALDH1A1
SCHEMBL4665324 0.69 MEN1 (0.64) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL11899820 0.68 MEN1 (0.41) MEN1KMT2ARAB9AKDM4EALDH1A1
SCHEMBL5458059 0.68 ALDH1A1 (0.61) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL18205210 0.67 MEN1 (0.58) MEN1KMT2AMAPTL3MBTL1POLB
SCHEMBL12226492 0.67 MEN1 (0.61) MEN1KMT2AMAPTL3MBTL1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043024-A1 Azacyclic compounds as inhibitors of sensory neurone specific channels IONIX PHARMACEUTICALS LIMITED (GB) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043024-A1 Azacyclic compounds as inhibitors of sensory neurone specific channels SCN1B, SCN1A, SCN10A MEN1 2444/4885KMT2A 2911/4885MAPT 2361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.